Pre-clinical investigations of repurposed and novel compounds that reduce or eliminate synucleinopathy in a human neuronal model of Parkinson

Project Details

StatusActive
Effective start/end date28/10/191/05/22

Funding

  • UK-based charities: £77,392.00